3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
30
Glioblastoma
28
Breast Neoplasms
19
Lung Neoplasms
18
Carcinoma, Non-Small-Cell Lung
17
Oropharyngeal Neoplasms
14
Squamous Cell Carcinoma of Head and Neck
11
Sarcoma
10
Glioma
10
Esophageal Neoplasms
10
Brain Neoplasms
10
Urinary Bladder Neoplasms
9
Astrocytoma
9
Neoplasm Metastasis
8
Gliosarcoma
8
Triple Negative Breast Neoplasms
7
Mouth Neoplasms
7
Head and Neck Neoplasms
7
Uterine Cervical Neoplasms
6
Rectal Neoplasms
6
Melanoma
6
Carcinoma, Hepatocellular
6
Carcinoma
6
Adenocarcinoma Of Esophagus
6
Stomach Neoplasms
5
Pancreatic Neoplasms
5
Neoplasms
5
Laryngeal Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Carcinoma, Squamous Cell
5
Interventions
pembrolizumab
6
Cetuximab
5
olaparib
3
atezolizumab
3
Injections
3
fludarabine
2
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Bevacizumab
2
zimberelimab
1
zansecimab
1
tocilizumab
1
taxane
1
spartalizumab
1
somatostatin receptor 2
1
ribociclib
1
pralsetinib
1
pertuzumab
1
pegylated granulocyte colony-stimulating factor
1
lenvatinib
1
ipatasertib
1
inavolisib
1
fludarabine phosphate
1
entrectinib
1
encorafenib
1
durvalumab
1
dapagliflozin
1
cemiplimab
1
brigimadlin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Solid Tumors
×
Radiation
×
1 year
×
Clear all
No trials found.